Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients.

Antoine MouiStéphanie DirouChristine SaganRenan LibergeClaire DefrancePierre-Paul ArrigoniOlivier MorlaChristine Kandel-AznarLaurent CellerinArnaud CavaillesEmmanuel EschapasseFlorent MorioPierre-Antoine GourraudThomas GoronflotAdrien TissotFrançois-Xavier Blanc

Published in: BMC pulmonary medicine (2022)

Our study highlights the additional value of BAL qualitative description in ILD. We suggest incorporating the immune alveolitis profile for the diagnosis and management of ILD, especially in immunocompromised patients, since it guides towards specific diagnoses.

Keyphrases

interstitial lung disease
end stage renal disease
systemic sclerosis
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
rheumatoid arthritis
idiopathic pulmonary fibrosis
systematic review
patient reported